GenSight Biologics S.A.
GSGTF
$0.24
-$0.08-25.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.15% | 21.67% | 567.15% | 574.96% | -79.20% |
| Total Receivables | -22.36% | -12.66% | -74.61% | -74.31% | -28.99% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -83.86% | -81.84% | -84.10% | -83.91% | -79.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 53.51% | 72.70% | 82.55% | 84.69% | -38.99% |
| Total Current Assets | -23.35% | -13.77% | -12.21% | -11.18% | -70.57% |
|
|
|||||
| Total Current Assets | -23.35% | -13.77% | -12.21% | -11.18% | -70.57% |
| Net Property, Plant & Equipment | -56.85% | -51.45% | -12.07% | -11.04% | -7.66% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -28.83% | -19.90% | -22.90% | -22.02% | -16.60% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 723.58% | 826.58% | -7.38% | -6.31% | -17.81% |
| Total Assets | 10.32% | 24.12% | -12.10% | -11.06% | -63.59% |
|
|
|||||
| Total Accounts Payable | 5.68% | 18.90% | -58.50% | -58.02% | -25.42% |
| Total Accrued Expenses | -9.21% | 2.13% | -54.55% | -54.01% | -48.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.10% | -15.73% | -57.51% | -57.01% | 640.04% |
| Total Finance Division Other Current Liabilities | 20.73% | 35.82% | 826.57% | 837.45% | -36.03% |
| Total Other Current Liabilities | 20.73% | 35.82% | 826.57% | 837.45% | -36.03% |
| Total Current Liabilities | -16.23% | -5.76% | -45.89% | -45.26% | 78.64% |
|
|
|||||
| Total Current Liabilities | -16.23% | -5.76% | -45.89% | -45.26% | 78.64% |
| Long-Term Debt | -13.80% | -3.02% | 183.22% | 186.55% | -63.47% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -54.07% | -48.31% | -14.21% | -13.19% | 11.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.91% | 23.65% | -5.62% | -4.51% | -22.16% |
| Total Liabilities | -11.41% | -0.33% | -10.78% | -9.73% | -0.05% |
|
|
|||||
| Common Stock & APIC | 2.01% | 14.76% | 9.75% | 11.04% | 9.21% |
| Retained Earnings | 49.99% | 43.73% | 52.02% | 51.45% | 1.83% |
| Treasury Stock & Other | -5.83% | -19.06% | -10.79% | -12.09% | -19.87% |
| Total Common Equity | 17.87% | 7.60% | 9.96% | 8.91% | -107.83% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.87% | 7.60% | 9.96% | 8.91% | -107.83% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.87% | 7.60% | 9.96% | 8.91% | -107.83% |
|
|
|||||